Fauna Bio
Focus: Fauna Bio leverages cross-mammalian genomics to discover human therapeutics, with current focus in oncology. The company operates as a pre-revenue biotech with a novel platform approach to drug discovery.
Profile data last refreshed 37m ago · AI intelligence enriched 2mo ago
Open Jobs
1+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at Fauna Bio?
AI assessmentFauna Bio is a high-risk, high-upside platform play best suited for early-career scientists comfortable with uncertainty and equity-focused compensation in exchange for scientific novelty.
Why Work Here
- Platform-driven approach offers exposure to cutting-edge genomics and translational science rare in early-stage biotech
- Located in Emeryville, CA with access to Bay Area biotech talent networks and institutional partnerships
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Interview Prep Quick Facts
Help build intelligence for Fauna Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.